Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Thomas De Nadaï"'
Autor:
Gaspard Grouteau, Cédric Mignonat, Bruno Marchou, Guillaume Martin-Blondel, Olivier Glass, Claire Roubaud-Baudron, Pauline Lansalot-Matras, Simon Alik, Laurent Balardy, Thomas De Nadaï, Lucie Bénéjat, Quentin Jehanne, Alain Le Coustumier, Philippe Lehours
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
In June 2021, a cluster of seven cases of Campylobacter fetus infections occurred in a rehabilitation center and caused significant morbidity in elderly patients including five with bacteremia and two with osteoarticular medical device infections. Th
Externí odkaz:
https://doaj.org/article/ecc50aae7558434ab67fffaf3c649b8b
Publikováno v:
Pathy's Principles and Practice of Geriatric Medicine. :331-341
Autor:
Guillaume Moulis, Daniel Adoue, Thibault Comont, Julien Maquet, Marc Michel, Nicolas Limal, Odile Beyne-Rauzy, Matthieu Mahévas, Bertrand Godeau, Thomas de Nadaï, Aurélien Sokal
Publikováno v:
British Journal of Haematology. 196:1262-1270
Data about the presentation and the management of primary immune thrombocytopenia (ITP) in very elderly patients (VEPs; aged ≥80 years) are lacking. The aim of the present study was to describe ITP in this subgroup. The data source was the prospect
Autor:
Marguerite, Briand, Thomas, De Nadaï, Laurent, Balardy, Yves, Rolland, Fatemeh, Nourhashemi, Sandrine, Sourdet, Bruno, Vellas
Publikováno v:
La Revue du praticien. 70(3)
Autor:
Mathilde François, Agnès Sommet, Thomas de Nadaï, Pierre Delobel, Guillaume Martin-Blondel, Marion Grare, Damien Dubois, Bruno Marchou, David Metsu
Publikováno v:
Infection
Infection, Springer Verlag, 2019, 47 (3), pp.463-469. ⟨10.1007/s15010-019-01290-w⟩
Infection, Springer Verlag, 2019, 47 (3), pp.463-469. ⟨10.1007/s15010-019-01290-w⟩
International audience; Purpose Teicoplanin is often used in Enterococcus faecalis infective endocarditis as a relay in case of penicillin side effects, or in outpatients. We assessed the efficacy of teicoplanin used as continuation therapy after ini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d26a5d04c4892c6cbf2000a423908101
https://hal.inrae.fr/hal-02618285
https://hal.inrae.fr/hal-02618285
Autor:
Aurélien Sokal, Thomas de Nadaï, Thibault Comont, Nicolas Limal, Marc Michel, Odile Beyne-Rauzy, Bertrand Godeau, Daniel Adoue, Matthieu Mahévas, Guillaume Moulis, Carmen investigators Group
Publikováno v:
Blood. 134:1091-1091
Introduction: The incidence of immune thrombocytopenia (ITP) is high in the elderly. Observational studies demonstrated that age above 65 years impacts ITP presentation and management. However, data are lacking in very elderly patients (VEP) with ITP